Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Parkinson's Disease
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01856439
- Collaborators
- Oxford BioMedica
- Investigators
- Principal Investigator: Stephane Palfi, Professor Henri Mondor University Hospital Principal Investigator: Roger Barker, Dr Addenbrookes Hospital
Get Well Soon